Efgartigimod, a therapy approved for certain autoimmune diseases, led to higher response rates and greater reductions in certain immune markers than a placebo in adults with Sjögren’s disease, according to final data from a small proof-of-concept clinical trial. Because the Phase 2 study, called RHO (NCT05817669), was not…
Women and men with Sjögren’s disease may experience the condition differently, particularly in the type and severity of symptoms and the organs affected, a study in the Netherlands suggests. While women were more likely to report dry eyes and dry mouth — the hallmark Sjögren’s symptoms — and…
People with Sjögren’s disease don’t only have to deal with eye and mouth dryness, but also a wide range of other symptoms that can include fatigue, pain, brain fog, and difficulty sleeping, according to a U.S. survey conducted by the Sjögren’s Foundation. In fact, results from the…
Blood levels of two self-targeting antibodies commonly elevated in people with Sjögren’s disease may define distinct patient groups with different levels of disease severity and organ involvement, a single-center study in China shows. For example, testing positive for anti-Ro52 antibodies alone was associated with lung disease, while testing positive…
Get regular updates to your inbox.
